Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Jul;39(7):1526–1529. doi: 10.1128/aac.39.7.1526

Cross-resistance to polyene and azole drugs in Cryptococcus neoformans.

T Joseph-Horne 1, D Hollomon 1, R S Loeffler 1, S L Kelly 1
PMCID: PMC162775  PMID: 7492098

Abstract

Fluconazole was observed to inhibit sterol 14 alpha-demethylase in the human pathogen Cryptococcus neoformans, and accumulation of a ketosteroid product was associated with growth arrest. A novel mechanism(s) of azole and amphotericin B cross-resistance was identified, unrelated to changes in sterol biosynthesis, as previously identified in Saccharomyces cerevisiae. Reduced cellular content of drug could account for the resistance phenotype, indicating the possible involvement of a mechanism similar to multidrug resistance observed in higher eukaryotes.

Full Text

The Full Text of this article is available as a PDF (185.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bozzette S. A., Larsen R. A., Chiu J., Leal M. A., Tilles J. G., Richman D. D., Leedom J. M., McCutchan J. A. Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS. Ann Intern Med. 1991 Aug 15;115(4):285–286. doi: 10.7326/0003-4819-115-4-285. [DOI] [PubMed] [Google Scholar]
  2. Kelly S. L., Lamb D. C., Taylor M., Corran A. J., Baldwin B. C., Powderly W. G. Resistance to amphotericin B associated with defective sterol delta 8-->7 isomerase in a Cryptococcus neoformans strain from an AIDS patient. FEMS Microbiol Lett. 1994 Sep 15;122(1-2):39–42. doi: 10.1111/j.1574-6968.1994.tb07140.x. [DOI] [PubMed] [Google Scholar]
  3. Nes W. D., Janssen G. G., Crumley F. G., Kalinowska M., Akihisa T. The structural requirements of sterols for membrane function in Saccharomyces cerevisiae. Arch Biochem Biophys. 1993 Feb 1;300(2):724–733. doi: 10.1006/abbi.1993.1100. [DOI] [PubMed] [Google Scholar]
  4. Rodriguez R. J., Low C., Bottema C. D., Parks L. W. Multiple functions for sterols in Saccharomyces cerevisiae. Biochim Biophys Acta. 1985 Dec 4;837(3):336–343. doi: 10.1016/0005-2760(85)90057-8. [DOI] [PubMed] [Google Scholar]
  5. Sokol-Anderson M. L., Brajtburg J., Medoff G. Amphotericin B-induced oxidative damage and killing of Candida albicans. J Infect Dis. 1986 Jul;154(1):76–83. doi: 10.1093/infdis/154.1.76. [DOI] [PubMed] [Google Scholar]
  6. Spitzer E. D., Spitzer S. G., Freundlich L. F., Casadevall A. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet. 1993 Mar 6;341(8845):595–596. doi: 10.1016/0140-6736(93)90354-j. [DOI] [PubMed] [Google Scholar]
  7. Stark G. R. Cancer chemotherapy. Progress in understanding multidrug resistance. Nature. 1986 Dec 4;324(6096):407–408. doi: 10.1038/324407a0. [DOI] [PubMed] [Google Scholar]
  8. Taylor F. R., Rodriguez R. J., Parks L. W. Requirement for a second sterol biosynthetic mutation for viability of a sterol C-14 demethylation defect in Saccharomyces cerevisiae. J Bacteriol. 1983 Jul;155(1):64–68. doi: 10.1128/jb.155.1.64-68.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Vanden Bossche H., Marichal P., Le Jeune L., Coene M. C., Gorrens J., Cools W. Effects of itraconazole on cytochrome P-450-dependent sterol 14 alpha-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans. Antimicrob Agents Chemother. 1993 Oct;37(10):2101–2105. doi: 10.1128/aac.37.10.2101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Watson P. F., Rose M. E., Ellis S. W., England H., Kelly S. L. Defective sterol C5-6 desaturation and azole resistance: a new hypothesis for the mode of action of azole antifungals. Biochem Biophys Res Commun. 1989 Nov 15;164(3):1170–1175. doi: 10.1016/0006-291x(89)91792-0. [DOI] [PubMed] [Google Scholar]
  11. Watson P. F., Rose M. E., Kelly S. L. Isolation and analysis of ketoconazole resistant mutants of Saccharomyces cerevisiae. J Med Vet Mycol. 1988 Jun;26(3):153–162. doi: 10.1080/02681218880000231. [DOI] [PubMed] [Google Scholar]
  12. Woods R. A. Nystatin-resistant mutants of yeast: alterations in sterol content. J Bacteriol. 1971 Oct;108(1):69–73. doi: 10.1128/jb.108.1.69-73.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Yoshida Y., Aoyama Y. Stereoselective interaction of an azole antifungal agent with its target, lanosterol 14 alpha-demethylase (cytochrome P-45014DM): a model study with stereoisomers of triadimenol and purified cytochrome P-45014DM from yeast. Chirality. 1990;2(1):10–15. doi: 10.1002/chir.530020103. [DOI] [PubMed] [Google Scholar]
  14. Zuger A., Louie E., Holzman R. S., Simberkoff M. S., Rahal J. J. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med. 1986 Feb;104(2):234–240. doi: 10.7326/0003-4819-104-2-234. [DOI] [PubMed] [Google Scholar]
  15. vanden Bossche H., Marichal P., Odds F. C., Le Jeune L., Coene M. C. Characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother. 1992 Dec;36(12):2602–2610. doi: 10.1128/aac.36.12.2602. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES